This content is from: Premium Another SPAC Merger Goes South RA Capital, Citadel, Farallon, Suvretta and Perceptive are under water on the recently closed merger between a biopharma company and RA Capital’s SPAC. By Stephen Taub July 22, 2021
This content is from: Portfolio GMO: Now Is the Time to Invest in Merger Arb Even though little has changed in the world of merger arbitrage in recent weeks, investors are acting like the world is a “scarier” place. That’s good news for investors, according to asset manager GMO. By Hannah Zhang September 01, 2021
This content is from: Premium Hedge Funds Eye SPAC Mergers A large number of firms, including Viking, Millennium, Citadel and Magnetar, have sizable stakes in at least three deals scheduled to be completed this week. By Stephen Taub September 27, 2021
This content is from: Portfolio Fewer Competitors, a SPAC Downturn, and Inflation Fears Are Fueling a Merger Arb Boom George Kellner, founder of one of the longest running hedge funds, hasn’t been this bullish in decades. By Julie Segal August 24, 2021
This content is from: Premium Taconic Launches New Vehicle to Take Advantage of Merger Arb Opportunities Event-driven and multi-strategy hedge fund firm Taconic has raised more than $1.5 billion in about 13 months. By Stephen Taub August 30, 2021
This content is from: Premium The Latest De-SPAC Debacle Casdin, Corvex, Soros, and Louis Bacon are among the victims of the latest ill-fated blank-check merger. By Stephen Taub December 23, 2021
